The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Measurement of PD-1, TIM-3 and LAG-3 protein in non-small cell lung carcinomas (NSCLCs) with acquired resistance to PD-1 axis blockers.
 
Ila Datar
No Relationships to Disclose
 
Nikita Mani
No Relationships to Disclose
 
Brian S. Henick
No Relationships to Disclose
 
Anna Wurtz
No Relationships to Disclose
 
Edward Kaftan
No Relationships to Disclose
 
Roy S. Herbst
Consulting or Advisory Role - AstraZeneca; Genentech/Roche; Lilly; Merck; Pfizer
Research Funding - Genentech; Merck
 
David L. Rimm
Stock and Other Ownership Interests - Metamark Genetics
Honoraria - Amgen; AstraZeneca; Bristol-Myers Squibb; Cell Signaling Technology; Genentech
Consulting or Advisory Role - AstraZeneca; Bethyl Laboratories; Biocept; Bristol-Myers Squibb; Cernostics; Five Prime Therapeutics; Genoptix; Optra SCAN; Perkin Elmer
Research Funding - Cepheid; Gilead Sciences; Kolltan Pharmaceuticals; OncoPlex Diagnostics; Perkin Elmer; Pierre Fabre (Inst)
Patents, Royalties, Other Intellectual Property - Quantitative Immunofluorescence (AQUA) (Inst); Rarecyte Circulating tumor cells
Travel, Accommodations, Expenses - Ventana Medical Systems
 
Scott N. Gettinger
No Relationships to Disclose
 
Katerina A. Politi
Consulting or Advisory Role - Novartis
Research Funding - AstraZeneca; Kolltan Pharmaceuticals; Roche
Patents, Royalties, Other Intellectual Property - I am a co-inventor on a patent licensed by MSKCC to Molecular MD for T790M testing
Travel, Accommodations, Expenses - Novartis
 
Kurt Alex Schalper
No Relationships to Disclose